
Revance Therapeutics
Revance is a biotechnology company setting the new standard in healthcare501-1000 EmployeesActively Hiring
- B2C
- Public StagePublicly traded company
Revance Therapeutics Funding
$113.6M
44 rounds
Revance Therapeutics is active in the following markets / industries: biotechnology, health care and FinTech. The company has secured funding across 4 rounds, totaling in an amount of $113.6M. Their most recent funding was raised on October 24, 2013.
Funding Rounds
U
$10000000U
$33000000D
$45000000D
$25600000Investors of Revance Therapeutics
Medicis Pharmaceutical
Pac-Link
Bio*One Capital
Shepherd Ventures
Technology Partners
Education space providing innovative and tested solutions in Kenya
LLC
Custom Living
Vivo Capital
CNF Investments
Rounds
D
Palo Alto Investors
Rounds
D